Clinical parkinsonism in dementia patients with substantia nigra Lewy bodies.
In a retrospective clinicopathological study, we examined the substantia nigra (SN) of 48 dementia patients with SN Lewy bodies (LBs) to determine if the severity of degeneration correlated with either the occurrence of signs of parkinsonism at dementia presentation or with the frequency of treatment for parkinsonism during the disease course. The SN specimens were graded for microscopic degeneration using a semi-quantitative five-tiered scale. Whereas no correlation was found between the grade of degeneration and occurrence of signs at presentation (r = -0.16, p = 0.18), with 16 of 38 patients having had signs reported, a more severe grade was statistically correlated with an increased frequency of treatment during the course (r = 0.41, p = 0.004), with ten of 41 patients having been treated for parkinsonism. Contrary to our expectations, we found that fewer than half of the patients with the two most severe grades of degeneration presented with signs of parkinsonism or were ever treated for parkinsonism.
Ala
T A
TA
Alzheimer's Treatment and Research Center, Department of Neurology, Ramsey Clinic/HealthPartners, University of Minnesota, St. Paul, USA.
Yang
K H
KH
Sung
J H
JH
Frey
W H
WH
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003704:Dementia / Q000150:complications* / Q000473:pathology*; D006801:Humans; D016631:Lewy Bodies / Q000473:pathology*; D009410:Nerve Degeneration / Q000473:pathology; D010300:Parkinson Disease / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D012189:Retrospective Studies; D013378:Substantia Nigra / Q000473:pathology*
D014150:Antipsychotic Agents